Oncolab

What Oncolab does

Oncolab is a private, niche diagnostic laboratory headquartered in Pretoria, South Africa, specializing in haematological malignancies and solid tumours. The company serves clinical haematology, medical oncology, and radiation oncology practices with diagnostic capabilities that fall outside the scope of general diagnostic laboratories. Oncolab operates four laboratory sites across Gauteng: a Reference Laboratory in Garsfontein (Pretoria), the Pretoria East Laboratory inside Netcare Pretoria East, the Wilgers Laboratory co-located with ABJ Oncology Centre at Wilgers Hospital, and the Benoni Laboratory co-located with ABJ Oncology Centre in Benoni.

The company's service offering spans five integrated diagnostic departments: Haematology (full blood counts, bone marrow reporting, coagulation), Chemical Pathology (immunochemistry including tumour markers, serology, endocrinology), Molecular Diagnostics (PCR, NGS, diagnostic haematological panels, cell-free oncology panels, myeloid MRD assessment, IGHV testing for CLL, HLA typing), Immunology (flow cytometry for leukaemia and lymphoma diagnostics, leukaemia MRD, CD34 and CD3 enumeration), and Cytogenetics (karyotyping, bone marrow and tissue FISH). Oncolab also operates a web-based PatientPortal enabling patients to view test results online. The technical differentiation rests on the breadth and depth of its specialized molecular and cytogenetic assay menu rather than proprietary AI or software.

Oncolab generates revenue through fee-for-service diagnostic testing paid by referring clinical practices and their patients, operating as a B2B specialist laboratory rather than a direct-to-consumer provider. Go-to-market is referral-driven, anchored by co-location with ABJ Oncology Centres and direct relationships with hematologists and oncologists. Leadership is concentrated around two subspecialist hematopathologists — Dr Theo Gerdener (University of Pretoria MBChB, UCT Haematopathology, Clinical Haematology subspecialist) and Dr Robyn Marshall (Wits MMed, Royal College of Pathologists of Australasia) — whose credentials underpin the company's claim to niche, world-class standards. Pricing is not publicly disclosed and requires direct inquiry.

Name

Oncolab

Legal name

Oncolab

Website

https://oncolab.co.za

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Oncolab is a private niche diagnostic laboratory in Pretoria, South Africa, specializing in haematological malignancy and solid tumour diagnostics for clinical haematology, medical oncology, and radiation oncology practices across four Gauteng laboratory sites.

Ownership category

akta.pro rank

Product category

Oncology and Haematology Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

Keywords

• Oncology diagnostics services
• Haematology laboratory testing
• Molecular diagnostics services
• Cancer pathology laboratory
• Clinical hematology testing

Headquarters

HQ city

Pretoria

HQ country

South Africa

HQ region

Africa

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Distribution channels1 record

Core offering

Oncolab is a niche laboratory providing specialised diagnostics in haematological malignancies and solid tumours that are often outside the scope of practice of other diagnostic laboratories. The company supports clinical haematology, medical oncology and radiation oncology practices through five integrated service lines — Haematology, Chemical Pathology, Molecular Diagnostics, Immunology (Flow Cytometry), and Cytogenetics — and operates a PatientPortal for online result access.

Product overview

Oncolab is a niche laboratory providing specialised diagnostics in haematological malignancies and solid tumours. The company operates a platform of integrated diagnostic services spanning five core departments: Haematology (FBCs, bone marrow reporting, coagulation), Chemical Pathology (tumour markers, serology, endocrinology), Molecular Diagnostics (PCR, NGS, haematological and oncology panels, MRD assessment, HLA typing), Immunology (flow cytometry for leukaemia/lymphoma diagnostics, CD34/CD3 enumeration), and Cytogenetics (karyotyping, FISH). The company also provides a PatientPortal web portal for patients to access their results online. These services are designed to support clinical haematology, medical oncology, and radiation oncology practices across multiple laboratory locations in South Africa.

Differentiator

Problem solved

Functional benefit

Products and services

• Haematology Services

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Recent moves1 record

Expansion highlights3 records

Broad incumbents

• Guardant Health: Specialty oncology diagnostics company best known for liquid biopsy and cell-free tumor DNA testing. Comparable to Oncolab's molecular diagnostics offering, including the cell-free oncology panels in Oncolab's menu, though operating at significantly larger scale.
• Foundation Medicine: Specialty molecular diagnostics provider focused on comprehensive genomic profiling of solid tumors and hematologic malignancies using NGS. Comparable in the molecular oncology diagnostics space, but operating at much larger scale as part of Roche.
• National Health Laboratory Service (NHLS): South Africa's largest public-sector diagnostic laboratory network, providing hematology and oncology testing across the public health system. Comparable as the dominant national reference lab in the same specialty space, though focused on public-sector demand.

Direct peers

• Neogenomics: US-based specialty reference laboratory focused exclusively on oncology diagnostics, including hematologic malignancy NGS panels, MRD, FISH, karyotyping, and flow cytometry. Closely comparable to Oncolab in pure-play oncology/hematology lab focus and service menu.
• Veracyte: Genomic diagnostics company focused on oncology and other specialty indications, providing molecular tests that inform treatment decisions. Comparable as a specialty molecular diagnostics lab with oncology-focused offerings.
• Caris Life Sciences: US molecular diagnostics company specializing in oncology profiling using NGS, including solid tumor and hematologic malignancy panels. Comparable to Oncolab in deploying advanced molecular oncology diagnostics as a specialized reference lab.
• Lancet Laboratories: Major South African private pathology chain with broad hematology, oncology, and molecular diagnostics capabilities across multiple provinces. Directly comparable to Oncolab as a competing private diagnostic laboratory serving clinicians and hospitals in South Africa.
• Ampath: One of South Africa's largest private pathology laboratory networks, offering comprehensive hematology and oncology diagnostics including flow cytometry, molecular, and cytogenetics. Directly comparable as a competing South African diagnostic lab, and a former employer of Oncolab's Dr Robyn Marshall.

Emerging players

• Invitae: Genetics company offering hereditary cancer and hematology-related genetic testing panels, including NGS-based diagnostics. Comparable in the molecular diagnostics space relevant to oncology/hematology, though broader than Oncolab's solid-tumour and heme focus.

Others

• ABJ Oncology Centre: South African oncology treatment group with which Oncolab is co-located at both Wilgers and Benoni sites. Not a direct competitor but a key clinical partner/referral channel that anchors Oncolab's oncology case volume.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Oncolab-Diagnostics-100066319637124
• LinkedInlinkedin.com/company/oncolab-diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncolab